Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mepenzolate bromide

Known as: N-methyl-3-piperidylbenzilate methyl bromide, mepenzolic acid, bromine salt 
 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

BenzilatesPiperidines

Narrower (1)

Cantil
MepenzolateMepenzolate 25 MG Oral Tablet [Cantil]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity
The standard treatment for chronic obstructive pulmonary disease is a combination of anti-inflammatory drugs and bronchodilators… Expand
  • table 2
  • figure 1
  • table 1
  • figure 2
  • figure 3
2017
2017
Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis
Butyrate and niacin are produced by gut microbiota, however butyrate has received most attention for its effects on colonic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
Mepenzolate bromide promotes diabetic wound healing by modulating inflammation and oxidative stress.
Diabetic wounds are characterized by persistent inflammation and the excessive production of reactive oxygen species, thus… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease
We recently proposed that mepenzolate bromide (mepenzolate) would be therapeutically effective against chronic obstructive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Ameliorative Effect of Mepenzolate Bromide against Pulmonary Fibrosis
Idiopathic pulmonary fibrosis is thought to involve lung injury caused by reactive oxygen species (ROS), which in turn is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2014
2014
Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.
Chronic obstructive pulmonary disease (COPD) is characterized by abnormal inflammatory responses and airflow limitations. We… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2013
2013
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.
The clinical treatment of chronic obstructive pulmonary disease (COPD) requires not only an improvement of airflow by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1983
1983
Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea.
Seventy adults in the United States with acute diarrhea who were attending classes in Guadalajara, Mexico, enrolled in a double… Expand
1979
1979
Mianserin and agranulocytosis.
An alcoholic woman who was admitted to hospital for detoxification was prescribed thyroxine because of hypothyroidism and… Expand
1972
1972
Oral absorption of 14 C-labeled mepenzolate bromide in humans.
In a pilot study, a single oral dose of 25 or 30 mg. of mepenzolate bromide containing approximately 24μc. of 14C was given to… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE